Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

MRVI

Maravai LifeSciences Holdings, Inc.

Healthcare · USD

Set alert

Price alert · MRVI

All alert types
7.81 USD -0.65 -7.68%
As of Oct 30, 2026 Extended hours 7.81 0.00%
Bid
7.80 × 2
Ask
7.81 × 2
7.68 Day range 8.48
2.83 52-week range 9.00
YTD
+140.31%
1 year
+148.73%
Open
8.37
Prev close
8.46
Mkt cap
2.89B
Vol
1.70M
Avg vol
3.17M
EPS
-0.53
P/E
0.00
Div yield
0.00%
More statistics
Low
7.68
High
8.48
Forward P/E
-77.59
Beta
0.54
Short ratio
4.94
Inst. own
99.16%
Dividend
0.00
Ex-div date
Earnings
Nov 4, 2026
50-d avg
7.51
200-d avg
5.22
1y target
8.50

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for MRVI has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

5.31 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 2

Valuation

P/E -3.6×
FY 2018: -149×FY 2019: -555×FY 2020: 3.8×FY 2021: 26.4×FY 2022: 8.6×FY 2023: -7.3×FY 2024: -5.2×FY 2025: -3.6×
FY 2018 5y median -3.6× FY 2025
P/S 2.5×
FY 2018: 21.4×FY 2019: 20.2×FY 2020: 9.5×FY 2021: 6.0×FY 2022: 2.1×FY 2023: 3.0×FY 2024: 2.9×FY 2025: 2.5×
FY 2018 5y median 2.9× FY 2025
P/B 2.2×
FY 2018: 18.4×FY 2019: 20.4×FY 2020: 30.6×FY 2021: 15.2×FY 2022: 3.5×FY 2023: 2.1×FY 2024: 2.3×FY 2025: 2.2×
FY 2018 5y median 2.3× FY 2025
P/FCF -6.7×
FY 2018: -699×FY 2019: 414×FY 2020: 21.4×FY 2021: 13.6×FY 2022: 3.6×FY 2023: 14.2×FY 2024: -33.9×FY 2025: -6.7×
FY 2018 5y median 3.6× FY 2025
EV/EBITDA -4.9×
FY 2018: 162×FY 2019: 122×FY 2020: 39.9×FY 2021: 15.7×FY 2022: 5.8×FY 2023: 2.4×FY 2024: -9.5×FY 2025: -4.9×
FY 2018 5y median 2.4× FY 2025
EV/Sales 3.9×
FY 2018: 43.4×FY 2019: 40.9×FY 2020: 19.4×FY 2021: 11.5×FY 2022: 4.0×FY 2023: 5.8×FY 2024: 5.7×FY 2025: 3.9×
FY 2018 5y median 5.7× FY 2025
FCF Yield -15.0%
FY 2018: -0.1%FY 2019: 0.2%FY 2020: 4.7%FY 2021: 7.4%FY 2022: 27.6%FY 2023: 7.0%FY 2024: -3.0%FY 2025: -15.0%
FY 2018 5y median 7.0% FY 2025

Profitability

Gross Margin 18.0%
FY 2018: 50.9%FY 2019: 53.3%FY 2020: 72.0%FY 2021: 82.4%FY 2022: 80.9%FY 2023: 48.5%FY 2024: 41.8%FY 2025: 18.0%
FY 2018 5y median 48.5% FY 2025
Operating Margin -3.6%
FY 2018: 13.3%FY 2019: 16.8%FY 2020: 42.2%FY 2021: 69.4%FY 2022: 65.0%FY 2023: -11.0%FY 2024: -90.9%FY 2025: -3.6%
FY 2018 5y median -3.6% FY 2025
Net Margin -70.4%
FY 2018: -14.3%FY 2019: -5.9%FY 2020: 27.1%FY 2021: 22.8%FY 2022: 24.9%FY 2023: -41.2%FY 2024: -55.9%FY 2025: -70.4%
FY 2018 5y median -41.2% FY 2025
ROE -61.6%
FY 2018: -12.3%FY 2019: -6.0%FY 2020: 86.9%FY 2021: 57.7%FY 2022: 40.4%FY 2023: -28.6%FY 2024: -44.5%FY 2025: -61.6%
FY 2018 5y median -28.6% FY 2025
ROIC -0.9%
FY 2018: 3.2%FY 2019: 3.9%FY 2020: 10.1%FY 2021: 26.7%FY 2022: 23.4%FY 2023: 0.5%FY 2024: -24.2%FY 2025: -0.9%
FY 2018 5y median 0.5% FY 2025
ROA -17.0%
FY 2018: -3.3%FY 2019: -1.5%FY 2020: 6.1%FY 2021: 9.5%FY 2022: 9.6%FY 2023: -8.0%FY 2024: -14.4%FY 2025: -17.0%
FY 2018 5y median -8.0% FY 2025

Growth (YoY)

Revenue -28.3%
FY 2018: 0.0%FY 2019: 15.6%FY 2020: 98.5%FY 2021: 181.3%FY 2022: 10.5%FY 2023: -67.3%FY 2024: -10.3%FY 2025: -28.3%
FY 2018 FY 2025
Operating Income 97.1%
FY 2018: 0.0%FY 2019: 45.9%FY 2020: 399.8%FY 2021: 362.6%FY 2022: 3.5%FY 2023: -105.5%FY 2024: -644.5%FY 2025: 97.1%
FY 2018 FY 2025
EPS (diluted) 13.3%
FY 2018: 0.0%FY 2019: 73.1%FY 2020: 4486.6%FY 2021: -33.9%FY 2022: 7.1%FY 2023: -153.9%FY 2024: -16.7%FY 2025: 13.3%
FY 2018 FY 2025
Free Cash Flow -218.7%
FY 2018: 0.0%FY 2019: 283.5%FY 2020: 1719.7%FY 2021: 179.0%FY 2022: 46.7%FY 2023: -88.3%FY 2024: -136.6%FY 2025: -218.7%
FY 2018 FY 2025

Financial Health

Current Ratio 6.6×
FY 2018: 1.5×FY 2019: 2.0×FY 2020: 2.5×FY 2021: 7.9×FY 2022: 7.7×FY 2023: 8.0×FY 2024: 7.5×FY 2025: 6.6×
FY 2018 5y median 7.7× FY 2025
Quick Ratio 5.7×
FY 2018: 1.1×FY 2019: 1.6×FY 2020: 2.3×FY 2021: 7.3×FY 2022: 7.3×FY 2023: 7.4×FY 2024: 6.7×FY 2025: 5.7×
FY 2018 5y median 7.3× FY 2025
Debt / Equity 0.2×
FY 2018: 2.4×FY 2019: 2.8×FY 2020: 6.7×FY 2021: 1.8×FY 2022: 1.1×FY 2023: 1.5×FY 2024: 1.2×FY 2025: 0.2×
FY 2018 5y median 1.2× FY 2025
Net Debt / EBITDA 1.2×
FY 2018: 9.6×FY 2019: 7.6×FY 2020: 2.6×FY 2021: 0.0×FY 2022: -0.1×FY 2023: 0.1×FY 2024: -0.3×FY 2025: 1.2×
FY 2018 5y median 0.0× FY 2025
Interest Coverage -0.2×
FY 2018: 0.6×FY 2019: 0.8×FY 2020: 3.9×FY 2021: 18.3×FY 2022: 28.1×FY 2023: -0.7×FY 2024: -4.9×FY 2025: -0.2×
FY 2018 5y median -0.2× FY 2025

Dividends

Dividend Yield 0.0%
FY 2018: 2.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018: -293.6%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31